Structure Therapeutics Inc. — Form 4
Filed July 15, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 49/100
What the filing says
CHIEF SCIENTIFIC OFFICER Lin Xichen (GPCR) sold 55K shares (~$402K) on the open market (97% of holdings). Large sale — ~97% of holdings.
Why this rating
Large sale — ~97% of holdings.
See more from July 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.